| Literature DB >> 35905266 |
Danfeng Dai1, Sijia Tu1, Zhichao Gao1.
Abstract
Postoperative ischemic stroke in middle-aged and elderly patients with hip or knee arthroplasty remains a major postoperative challenge, little is known about its incidence and risk factors. This study sought to create a nomogram for precise prediction of ischemic stroke after hip or knee arthroplasty. Discharge data of all middle-aged and elderly patients undergoing primary hip or knee arthroplasty from May 2013 to October 2020 were queried. These patients were then followed up over time to determine their risk of ischemic stroke. Clinical parameters and blood biochemical features were analyzed by the use of univariable and multivariable generalized logistic regression analysis. A nomogram to predict the risk of ischemic stroke was constructed and validated with bootstrap resampling. Eight hundred twenty-eight patients were included for analysis; Fifty-one were diagnosed with ischemic stroke. After final regression analysis, age, the neutrophil-to-lymphocyte ratio (NLR), a standard deviation of red blood cell distribution width, American Society of Anesthesiologists, low-density lipoprotein, and diabetes were identified and were entered into the nomogram. The nomogram showed an area under the receiver operating characteristic curve of 0. 841 (95% confidence interval [CI], 0.809-0.871). The calibration curves for the probability of ischemic stroke showed optimal agreement between the probability as predicted by the nomogram and the actual probability (Hosmer-Lemeshow test: P = .818). We developed a practical nomogram that can predict the risk of ischemic stroke for middle-aged and elderly patients with hip or knee arthroplasty. This model has the potential to assist clinicians in making treatment recommendations.Entities:
Mesh:
Year: 2022 PMID: 35905266 PMCID: PMC9333551 DOI: 10.1097/MD.0000000000029542
Source DB: PubMed Journal: Medicine (Baltimore) ISSN: 0025-7974 Impact factor: 1.817
Figure 1.The flow chart of patient selection and data process.
Baseline demographic and clinical characteristics of included patients diagnosed with or without ischemic stroke.
| Ischemic stroke | |||||
|---|---|---|---|---|---|
| Variables | Level | Overall(N = 828) | Yes(N = 51) | No(N = 777) | P-value |
| Age (median [IQR]),yr | 61.00 [55.00, 70.00] | 63.00 [59.00, 71.00] | 61.00 [54.00, 70.00] | .05 | |
| Sex (%) | Female | 190 (22.9) | 24 (47.1) | 166 (21.4) | .07 |
| Male | 638 (77.1) | 27 (52.9) | 611 (78.6) | ||
| ASA classification (%) | I | 458 (55.3) | 13 (25.5) | 445 (57.3) | .02 |
| II | 370 (44.7) | 38 (74.5) | 332 (42.7) | ||
| Hypertension (%) | Yes | 655 (79.1) | 33 (64.7) | 622 (80.1) | .37 |
| No | 173 (20.9) | 18 (35.3) | 155 (19.9) | ||
| Diabetes (%) | Yes | 623 (75.2) | 32 (62.7) | 591 (76.1) | .02 |
| No | 205 (24.8) | 19 (37.3) | 186 (23.9) | ||
| Coronary disease (%) | Yes | 185 (22.3) | 4 (7.8) | 181 (23.3) | .23 |
| No | 643 (77.7) | 47 (92.2) | 596 (76.7) | ||
| Smoking (%) | Yes | 601 (72.6) | 44 (86.3) | 557 (71.7) | .28 |
| No | 227 (27.4) | 7 (13.7) | 220 (28.3) | ||
| Drinking (%) | Yes | 653 (78.9) | 36 (70.6) | 617 (79.4) | .95 |
| No | 175 (21.1) | 15 (29.4) | 160 (20.6) | ||
| BMI (median [IQR]), Kg/m2 | 26.00 [18.00, 31.00] | 28.00 [21.00, 31.00] | 26.00 [21.00, 29.00] | .87 | |
| SBP (median [IQR]),mm Hg | 126.50 [109.00, 142.00] | 119.00 [104.75, 129.50] | 127.50 [109.00, 142.75] | .23 | |
| DBP (median [IQR]),mm Hg | 83.00 [73.00, 92.00] | 87.00 [73.00, 90.50] | 83.00 [73.00, 92.00] | .96 | |
| RDW-SD (median [IQR]) | 16.50 [14.00, 18.75] | 16.00 [13.00, 18.50] | 16.00 [14.00, 18.00] | .43 | |
| RBC (median [IQR]),10^12/L | 4.72 [2.12, 6.23] | 4.12 [2.65, 5.63] | 3.46 [2.14, 6.17] | .22 | |
| PLT (median [IQR]),10^9/L | 200.00 [155.00, 260.50] | 198.50 [158.25, 241.00] | 200.00 [155.00, 263.50] | .64 | |
| NC (median [IQR]),% | 4.16 [3.12, 6.46] | 2.21 [1.23, 3.54] | 4.23 [2.25, 5.65] | .01 | |
| LC (median [IQR]),% | 2.08 [1.13, 3.23] | 3.21 [2.75, 3.78] | 1.56 [1.02, 3.18] | .01 | |
| LDL-C (median [IQR]),mmol/L | 3.02 [2.04, 4.14] | 3.23 [2.75, 3.25] | 2.03 [1.54, 3.25] | .05 | |
| HDL-C (median [IQR]),mmol/L | 3.25 [3.12, 5.35] | 4.25 [3.21, 5.56] | 3.25 [2.12, 4.75] | .33 | |
| TC (median [IQR]),mmol/L | 5.25 [4.15, 6.25] | 5.15 [4.15, 6.25] | 4.12 2.55, 5.25] | .05 | |
| TG (median [IQR]),mmol/L | 2.85 [1.24, 3.57] | 2.26 [1.75, 3.45] | 2.07 [1.21, 3.15] | .39 | |
| Scr (median [IQR]), ľmol/L | 121.00 [37.00, 146.00] | 140.00 [35.50, 156.50] | 82.00 [37.00, 146.00] | .12 | |
Univariate and multivariate logistic regression analysis for risk factors associated with apoplexy in patients with hip or knee arthroplasty.
| Univerate | Multivariate | |||
|---|---|---|---|---|
| Variables | OR(95%CI) | P-value | OR(95%CI) | P-value |
| Age | 1.26 (0.86–1.83) | .02 | 1.31 (0.85–2.01) | .01 |
| ASA | ||||
| II | Reference | Reference | ||
| I | 0.09 (0.01–0.64) | 0.27 (0.03–2.34) | ||
| Diabetes | ||||
| No | Reference | Reference | ||
| Yes | 19.79 (9.93–39.39) | 5.69 (2.59–12.50) | ||
| LDL-C | ||||
| >3.6 | Reference | Reference | ||
| =3.6 | 3.92 (2.04–7.53) | 2.30 (1.10–4.81) | ||
| RDW | ||||
| >13 | Reference | Reference | ||
| =13 | 3.79 (2.01–7.16) | 2.36 (1.15–4.85) | ||
| NLR | ||||
| Reference | Reference | |||
| =3.17 | 4.78 (3.84–5.72) | 5.81 (4.86–6.75) | ||
| LMR | ||||
| Reference | Reference | |||
| =3.6 | 2.51 (1.57–3.45) | 2.24 (1.29–3.18) | .23 | |
| PLR | ||||
| Reference | Reference | |||
| =197 | 1.46 (0.52–2.40) | 1.07 (0.12–2.01) | .21 | |
| Smoking | ||||
| No | Reference | Reference | ||
| Yes | 3.91 (2.97–4.85) | 4.67 (3.73–5.61) | .07 | |
Figure 2.Nomogram to estimate the risk of ischemic stroke. (A) A nomogram for predicting the risk of ischemic stroke showing the proportion (%) of parameters included in the score scale. To use the nomogram score, it is important to identify the point of each variable on the corresponding axis; the total number of points can then be summated from all variables. (B) Radar plot showing the relative weight of candidate parameters arising from stepwise regression analysis. (C) Decision curve for the prediction of ischemic stroke. Decision curve analysis identified potential factors that can exert clinical influence based on stepwise regression analysis and the net benefit of using nomogram scores to stratify patients.
Figure 3.The predictive performance of different models. A. Receiver operating characteristic (ROC) curve for five models. B. Clinical impact curve for the ischemic stroke nomogram score. Notes. The purple line predicts the probability of patients who would show low risk to ischemic stroke. The red line calculated for predmodelB shows how many patients would be at a high risk of ischemic stroke.